Pressure BioSciences' Penetration in European Biopharma and High Pressure Markets Continuing to Expand via Multiple Scientific Presentations in Germany, Poland, and Ireland
Pressure BioSciences, Inc. (PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that multiple presentations have highlighted features and benefits of the Company's recently-released, next-generation Barocycler 2320EXTREME instrument (the "Barocycler 2320EXT") at scientific meetings in Germany, Poland, and Ireland over the past 30 days.Pressure BioSciences' Barocycler 2320EXTREME to Be Featured in Multiple Presentations All Week at Major Scientific Meeting
Pressure BioSciences, Inc. (OTCMKTS:PBIOD) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that the Company's patented PCT platform will be featured in multiple presentations at the annual conference of the American Society for Mass Spectrometry ("ASMS"), being held from June 4-8, 2017 in Indianapolis, IN.Dr. Ruedi Aebersold Receives the Prestigious Karger Medal Recognizing an Individual Who Has Significantly Contributed to the Development of New Bioanalytical Methods
Pressure BioSciences, Inc. (OTCMKTS:PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that Dr. Ruedi Aebersold recently received the prestigious Karger Medal from the Barnett Institute of Chemical & Biological Analysis at Northeastern University in Boston MA. The Medal is awarded biennially to honor Dr. Barry Karger, the founding director of the Barnett Institute. The award recognizes an individual who has significantly contributed to the development of new bioanalytical methods.Pressure BioSciences, Inc. Announces One-for-Thirty Reverse Stock Split
Pressure BioSciences, Inc. (OTCMKTS:PBIO) ("PBI" or the "Company") today announced a one-for-thirty reverse split of its common stock effective as of Monday, June 5, 2017. The shares underlying the Company's outstanding convertible securities will also be adjusted accordingly.Pressure BioSciences, Inc. Reports First Quarter 2017 Financial Results and Provides Business Update
Pressure BioSciences, Inc. (OTCMKTS:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced financial results for the first quarter of 2017, provided a business update, and offered limited guidance on its growth plan for FY2017.Pressure BioSciences, Inc. to Discuss First Quarter 2017 Financial Results and Provide Business Update
Pressure BioSciences, Inc. (OTCMKTS:PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its First Quarter 2017 financial results and to provide a business update. Anyone interested may listen to the teleconference either live (by telephone) or through a replay approximately one day after the call (by telephone or via a link on the Company's website).Pressure BioSciences, Inc. Significantly Expands Marketing and Sales Capabilities
Pressure BioSciences, Inc. (OTCMKTS:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that it has significantly bolstered its marketing and sales capabilities by contracting with well-known and highly regarded EKG Sales Associates, and by hiring two of its planned four additional field sales directors. For the past few years, the Company's selling efforts have relied on two part-time field sales directors in the U.S. and several distribution partners internationally.Pressure BioSciences, Inc. Reports Fourth Quarter and Fiscal Year 2016 Financial Results and Provides Business Update
Pressure BioSciences, Inc. (OTCMKTS:PBIO) ("PBI" or the "Company") today announced financial results for the fourth quarter and fiscal year ended December 31, 2016, provided a business update, and offered limited guidance for FY2017.Pressure BioSciences Receives 2017 North American Excellence Award: Best New Instrument for Sample Preparation
Pressure BioSciences, Inc. (OTCMKTS:PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that its Barocycler 2320EXTREME ("2320EXT") has been named the "Best New Instrument for Sample Preparation 2017" by Corporate America News ("Corp America") as part of the publication's 2017 North American Excellence Awards.Pressure BioSciences Achieves CE Marking for Its Next Generation Sample Preparation Instrument, the Barocycler 2320EXTREME
Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that the Company has achieved CE Marking for the Barocycler 2320EXTREME ("2320EXT"), the Company's recently released, next-generation PCT-based sample preparation instrument. PBI is now permitted to begin sales of the Barocycler 2320EXT in the European Economic Area ("EEA").